CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 424B3 Offering Prospectus
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13D Stake Beneficial Ownership Report
- 4 Shares withheld for taxes SVP of Finance gave up 1,400 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,987 shares (to pay taxes)
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Delisting notice
- 425 Deal Prospectus/Communication re Business Combination
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Shares withheld for taxes SVP of Finance gave up 100 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 170 shares (to pay taxes)
- UPLOAD Other SEC-generated Letter
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 22 of 77 · 1,525 filings